Font Size: a A A
Keyword [survival analysis]
Result: 1 - 20 | Page: 1 of 10
1. The Study Of Diagnosis And Prediction Of Cox's Proportional Hazards Regression Model
2. The Results After Radical Mastectomy And Modified Radical Mastectomy For 730 Patients With Breast Cancer
3. The Value Of Chromosomal Microsatellite Alterations In Molecular Staging And Prognosis Prediction Of Hepatocellular Carcinoma
4. Screen For Prognostic Factors Of Spinal Metastases And Establishment Of Cox Model
5. Experience Of Organ Transplantation And Analysis Of Multivariate Factors That Influence Survival With Lung Cancer In Recipients
6. The Prognosis Of Ischemic Cardiomyopathy With Left Ventricular Dysfunction
7. Clinical Characteristics And Malignant Mechanism Of Ovarian Cancer Associated With Endometriosis
8. Chinese HIV / AIDS Patients Underwent ART Loss Rate And Survival Analysis
9. Survival Analysis And Early Screening Of Endometrial Cancer Patients
10. Effect Of Common EGFR Mutant Genotype On Second - Line Treatment Strategy Of Advanced Lung Adenocarcinoma
11. The Prognostic Factor Of Ischemic Stoke Patients
12. Expresison Of E-cadherin And Adhesion Molecules Familial Members α-, β-, γ-, P120- Catenin In The Spinal Chordoma And Analysis Of The Correlating Prognosis
13. The Prognostic Value Of Tumor Infiltrating Immune Cells In Gastric Cardia Carcinoma Underwent Curative Resection
14. Clinical And Laboratory Study On Factors Associated With Radiation-induced-Lung-Injury And Survival Of Lung Cancer Patients
15. COX Proportional Hazards Model Analysis Of Prognostic Factors Impacting On Survival Of Prostate Cancer
16. Clinical Observation And Experimental Research On Hepatocellular Carcinoma Treated With Shen Tao Ruan Gan Recipe
17. Initial Investigation Of Clinical Staging Based On GTV-T Volume Of Esophageal Carcinoma
18. Traumatic Brain Injuries-Characteristics And Outcome Prediction
19. Gene Silencing Targeted On Peroxisome Proliferator-activated Receptor γ Affect Biological Behaviour Of Hepatoma
20. Lymphatic Metastasis Prediction For Endometrial Cancer: Implication Of Clinical Methods And Combined Molecular Markers
  <<First  <Prev  Next>  Last>>  Jump to